Code | 3672D | ||||||||||
MA number | 58/0039/20-S | ||||||||||
Product Form: | cps pld 100x90 mg (fľ.HDPE) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
Therapeutic Class: | 58 - HYPOTENSIVA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | bottle HDPE | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 20.03.2020 |
Pediatric warnings: | Yes |
PIL: | PIL_Urapidil Stada 90 mg_cps pld_03/2020_REG.doc |
SPC: | SPC_Urapidil Stada 90 mg_cps pld_03/2020_REG.doc |
Safety feature | Yes |
Data update: | 04.09.2024 |